BRAVELLE

LOE Approaching

urofollitropin

BLASubcutaneousInjectable
Approved
Dec 2002
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
2

Clinical Trials (2)

NCT01922193Phase 3Completed

Evaluation of Efficacy and Safety of Highly Purified Urofollitropin in Chinese Females Undergoing an Assisted Reproductive Technology (ART) Program

Started Oct 2013
263 enrolled
Infertility
NCT01923194Phase 3Completed

Evaluation of Efficacy and Safety of Highly Purified Urofollitropin for Ovulation Induction in Chinese Females

Started Oct 2013
215 enrolled
Anovulation